TSPO and Parkinson disease: Some initial studies reported high brain TSPO PET signal compared to controls in patients with AD, Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) and those at risk of Huntington’s disease (HD) [25,26,27,28,29,30,31,32,33].